Metalloproteinases 2 and -9 activity during promotion and progression stages of rat liver carcinogenesis
- 4 December 2008
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 40 (1) , 1-11
Abstract
Activity of metalloproteinases 2 and 9 (MMP-2 and 9) during promotion and progression of rat liver carcinogenesis was investigated in a modified resistant hepatocyte model. Development of preneoplastic liver lesions positive for glutathione S-transferase 7-7-(GST-P 7-7-positive PNL) and tumors besides hepatocytes positive for proliferating cell nuclear antigen (PCNA) were quantified and compared to MMP-2 and-9 activity using gelatin zymography. Marked increases in GST-P 7-7-positive PNL development, PCNA labeling indices, MMP-2 (pro, intermediate and active forms) and pro-MMP-9 activity were observed after proliferative stimulus induced by 2-acetylaminofluorene (2-AAF) exposure cycles. After 2-AAF withdrawal, increase in MMP-2 activity was detected only in neoplastic mixed lesions, whereas active MMP-9 was increased in both PLN and neoplastic tissues. Our findings suggest that MMP-2 may be associated with proliferative events induced by 2-AAF rather than with selective growth of PNL and that MMP-9 could be associated with progression of PNL and neoplastic mixed lesions.Keywords
This publication has 36 references indexed in Scilit:
- Chronic ethanol intake promotes double gluthatione S‐transferase/transforming growth factor‐α‐positive hepatocellular lesions in male Wistar ratsCancer Science, 2008
- Control of matrix metalloproteinase catalytic activityMatrix Biology, 2007
- H‐Ras selectively up‐regulates MMP‐9 and COX‐2 through activation of ERK1/2 and NF‐κB: An implication for invasive phenotype in rat liver epithelial cellsInternational Journal of Cancer, 2006
- Relevance of Hepatic Preneoplasia for Human HepatocarcinogenesisToxicologic Pathology, 2003
- Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesisHepatology, 2002
- 2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiationPharmacology & Therapeutics, 1996
- Quantitative and/or qualitative changes in the P21‐H‐ras post‐translational products in regenerating liver and during hepatocarcinogenesisInternational Journal of Cancer, 1993
- Dose-dependent effects of 2-acetylaminofluorene on hepatic foci development and cell proliferation in ratsCarcinogenesis, 1991
- Strain Differences in Susceptibility to 2-Acetylaminofluorene and Phenobarbital Promotion of Rat Hepatocarcinogenesis in a Medium-term Assay System: Quantitation of GlutathioneS-Transferase P-positive Foci DevelopmentJapanese Journal of Cancer Research, 1989
- Advantages and Limitations of Stereological Estimation of Placental Glutathione S‐Transferase‐positive Rat Liver Cell Foci by Computerized Three‐dimensional ReconstructionJapanese Journal of Cancer Research, 1989